Over-the-counter hearing aids
Hearing aids sold without a prescription.
Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 2, 1, 4, 6, 3.
All papers from the last 12 months
31 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- Over-the-Counter Hearing Aids 4 Years Later: Regulatory Reform Alone Is Insufficient to Ensure Consumer BenefitsJAMA2026 Oct 15PMID 42879164
- Evaluating the Effectiveness of Over-the-Counter Hearing Aids in Ageing Populations With Hearing LossJ Audiol Otol2026 Oct 13PMID 42861444
- Effectiveness of Over-the-Counter Hearing Aids Versus Professionally Fitted Devices: A Systematic Review and Meta-analysisOtolaryngol Head Neck Surg2026 OctPMID 42307981Meta-analysisSystematic reviewReview
- Self-Fitting Versus Professional-Fitting Hearing Aids: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsAudiol Res2026 Sep 19PMID 42776781Review
- Audiogram Interpretation2026 JanPMID 35201707
- Preferences for Over-the-Counter and Prescription Hearing Aid Processing Across Listening EnvironmentsAm J Audiol2026 Sep 3PMID 42622515
- Understanding Hearing Health Care Choices and Customer Archetypes in an Era of Over-the-Counter Hearing AidsAm J Audiol2026 Sep 3PMID 42536496
- An Evaluation of Preset Collection Size in Over-the-Counter Hearing AidsEar Hear2026 Sep-Oct 01PMID 42168802
- From policy debate to empirical evidence: a proof-of-concept bibliometric and LLM-assisted abstract-level content analysis of OTC hearing aid research before and after FDA regulationInt J Audiol2026 Aug 29PMID 42667154
- Extremely High Fitting Range and Dangerous Levels Permitted by the Current FDA Guidelines for OTC Hearing Aids and the Need to Consider RECDsAudiol Res2026 Aug 25PMID 42776766
More otorhinolaryngology trends
All specialties →Tinnitus
Tinnitus mechanisms and treatments, including neuromodulation.
Cochlear implants
Cochlear implantation, including in older adults and single-sided deafness.
Key point: Cochlear implant indications now include profound unilateral or bilateral sensorineural hearing loss, unilateral deafness, or residual hearing, determined individually for each ear.
Smell loss
Olfactory dysfunction, including after viral infection.
HPV-positive oropharyngeal cancer
HPV-related throat cancer and treatment de-escalation.
Transoral robotic surgery
Robotic surgery through the mouth for head and neck tumours.
Key point: In predominantly HPV-associated OPSCC treated with TORS, smoking history showed no significant difference in recurrence-free or disease-specific survival.
Eustachian tube balloon dilation
Balloon dilation for Eustachian tube dysfunction.
Key point: BDET may improve functional and audiological outcomes in pediatric ETD, but comparative evidence does not confirm superiority over standard management.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
"over-the-counter"[tiab] AND "hearing aid*"[tiab]Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.